DD154816B3 - Verfahren zur herstellung neuer pyridine - Google Patents

Verfahren zur herstellung neuer pyridine Download PDF

Info

Publication number
DD154816B3
DD154816B3 DD80224544A DD22454480A DD154816B3 DD 154816 B3 DD154816 B3 DD 154816B3 DD 80224544 A DD80224544 A DD 80224544A DD 22454480 A DD22454480 A DD 22454480A DD 154816 B3 DD154816 B3 DD 154816B3
Authority
DD
German Democratic Republic
Prior art keywords
compound
compounds
formula
conditions
inflammatory
Prior art date
Application number
DD80224544A
Other languages
German (de)
English (en)
Other versions
DD154816A5 (de
Inventor
Joseph G Lombardino
Charles A Harbert
Original Assignee
Pfizer
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer filed Critical Pfizer
Publication of DD154816A5 publication Critical patent/DD154816A5/de
Publication of DD154816B3 publication Critical patent/DD154816B3/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/24—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D213/28—Radicals substituted by singly-bound oxygen or sulphur atoms
    • C07D213/32—Sulfur atoms
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01D—HARVESTING; MOWING
    • A01D34/00—Mowers; Mowing apparatus of harvesters
    • A01D34/001—Accessories not otherwise provided for
    • A01D34/003—Means for cleaning the machine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B29—WORKING OF PLASTICS; WORKING OF SUBSTANCES IN A PLASTIC STATE IN GENERAL
    • B29C—SHAPING OR JOINING OF PLASTICS; SHAPING OF MATERIAL IN A PLASTIC STATE, NOT OTHERWISE PROVIDED FOR; AFTER-TREATMENT OF THE SHAPED PRODUCTS, e.g. REPAIRING
    • B29C33/00—Moulds or cores; Details thereof or accessories therefor
    • B29C33/56—Coatings, e.g. enameled or galvanised; Releasing, lubricating or separating agents
    • B29C33/60—Releasing, lubricating or separating agents
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B29—WORKING OF PLASTICS; WORKING OF SUBSTANCES IN A PLASTIC STATE IN GENERAL
    • B29C—SHAPING OR JOINING OF PLASTICS; SHAPING OF MATERIAL IN A PLASTIC STATE, NOT OTHERWISE PROVIDED FOR; AFTER-TREATMENT OF THE SHAPED PRODUCTS, e.g. REPAIRING
    • B29C70/00—Shaping composites, i.e. plastics material comprising reinforcements, fillers or preformed parts, e.g. inserts
    • B29C70/68—Shaping composites, i.e. plastics material comprising reinforcements, fillers or preformed parts, e.g. inserts by incorporating or moulding on preformed parts, e.g. inserts or layers, e.g. foam blocks
    • B29C70/84—Shaping composites, i.e. plastics material comprising reinforcements, fillers or preformed parts, e.g. inserts by incorporating or moulding on preformed parts, e.g. inserts or layers, e.g. foam blocks by moulding material on preformed parts to be joined
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/24—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D213/54—Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C07D213/55—Acids; Esters
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/62—Oxygen or sulfur atoms
    • C07D213/63—One oxygen atom
    • C07D213/65—One oxygen atom attached in position 3 or 5
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
    • C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
    • C07D239/26—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • F—MECHANICAL ENGINEERING; LIGHTING; HEATING; WEAPONS; BLASTING
    • F16—ENGINEERING ELEMENTS AND UNITS; GENERAL MEASURES FOR PRODUCING AND MAINTAINING EFFECTIVE FUNCTIONING OF MACHINES OR INSTALLATIONS; THERMAL INSULATION IN GENERAL
    • F16C—SHAFTS; FLEXIBLE SHAFTS; ELEMENTS OR CRANKSHAFT MECHANISMS; ROTARY BODIES OTHER THAN GEARING ELEMENTS; BEARINGS
    • F16C11/00—Pivots; Pivotal connections
    • F16C11/04—Pivotal connections
    • F16C11/06—Ball-joints; Other joints having more than one degree of angular freedom, i.e. universal joints
    • F16C11/0604—Construction of the male part
    • F—MECHANICAL ENGINEERING; LIGHTING; HEATING; WEAPONS; BLASTING
    • F16—ENGINEERING ELEMENTS AND UNITS; GENERAL MEASURES FOR PRODUCING AND MAINTAINING EFFECTIVE FUNCTIONING OF MACHINES OR INSTALLATIONS; THERMAL INSULATION IN GENERAL
    • F16C—SHAFTS; FLEXIBLE SHAFTS; ELEMENTS OR CRANKSHAFT MECHANISMS; ROTARY BODIES OTHER THAN GEARING ELEMENTS; BEARINGS
    • F16C11/00—Pivots; Pivotal connections
    • F16C11/04—Pivotal connections
    • F16C11/06—Ball-joints; Other joints having more than one degree of angular freedom, i.e. universal joints
    • F16C11/068—Special features relating to lubrication

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Health & Medical Sciences (AREA)
  • General Engineering & Computer Science (AREA)
  • Mechanical Engineering (AREA)
  • Immunology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Composite Materials (AREA)
  • Environmental Sciences (AREA)
  • Rheumatology (AREA)
  • Transplantation (AREA)
  • Pain & Pain Management (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Pyridine Compounds (AREA)
DD80224544A 1979-10-15 1980-10-14 Verfahren zur herstellung neuer pyridine DD154816B3 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US06/085,011 US4246263A (en) 1979-10-15 1979-10-15 Antiinflammatory and immunoregulatory pyrimidines, their method of use and pharmaceutical compositions

Publications (2)

Publication Number Publication Date
DD154816A5 DD154816A5 (de) 1982-04-21
DD154816B3 true DD154816B3 (de) 1987-05-13

Family

ID=22188737

Family Applications (2)

Application Number Title Priority Date Filing Date
DD80224544A DD154816B3 (de) 1979-10-15 1980-10-14 Verfahren zur herstellung neuer pyridine
DD82236826A DD202543A5 (de) 1979-10-15 1982-01-18 Verfahren zur herstellung neuer pyridine und pyrimidine

Family Applications After (1)

Application Number Title Priority Date Filing Date
DD82236826A DD202543A5 (de) 1979-10-15 1982-01-18 Verfahren zur herstellung neuer pyridine und pyrimidine

Country Status (39)

Country Link
US (1) US4246263A (ko)
JP (1) JPS5663962A (ko)
KR (2) KR840001614B1 (ko)
AR (3) AR226864A1 (ko)
AT (2) AT377513B (ko)
AU (1) AU517763B2 (ko)
BE (1) BE885709A (ko)
CA (1) CA1156231A (ko)
CH (1) CH646425A5 (ko)
CS (2) CS226020B2 (ko)
DD (2) DD154816B3 (ko)
DE (1) DE3038593A1 (ko)
DK (1) DK152427C (ko)
EG (1) EG14676A (ko)
ES (2) ES8201972A1 (ko)
FI (1) FI75560C (ko)
FR (1) FR2467199A1 (ko)
GB (2) GB2061928B (ko)
GR (1) GR70311B (ko)
HK (2) HK1185A (ko)
HU (2) HU191824B (ko)
IE (1) IE50665B1 (ko)
IL (1) IL61261A (ko)
IN (2) IN154554B (ko)
IT (1) IT1195269B (ko)
KE (2) KE3461A (ko)
LU (1) LU82844A1 (ko)
MY (2) MY8500323A (ko)
NL (1) NL8005652A (ko)
NO (1) NO156566C (ko)
NZ (1) NZ195246A (ko)
PH (1) PH18277A (ko)
PL (2) PL125402B1 (ko)
PT (1) PT71917B (ko)
SE (1) SE437023B (ko)
SG (2) SG56384G (ko)
SU (2) SU1083907A3 (ko)
YU (2) YU41740B (ko)
ZA (1) ZA806306B (ko)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4371696A (en) * 1980-07-14 1983-02-01 Pfizer Inc. Certain pyridine methylthio acetaldehyde derivatives and non-cyclic and cyclic acetals thereof
GB8405896D0 (en) * 1984-03-07 1984-04-11 Sandoz Ltd Organic compounds
EP0311616B1 (en) * 1986-06-17 1991-09-25 Biogen, Inc. Combinations of gamma interferons and anti-inflammatory or anti-pyretic agents for treating diseases
US6878743B2 (en) * 2001-09-18 2005-04-12 Sunesis Pharmaceuticals, Inc. Small molecule inhibitors of caspases
WO2006091870A2 (en) * 2005-02-25 2006-08-31 Temple University- Of The Commonwealth System Of Higher Education Unsaturated sulfides, sulfones, sulfoxides and sulfonamides synthesis
JP5287033B2 (ja) * 2007-08-23 2013-09-11 住友化学株式会社 含フッ素有機硫黄化合物およびその有害節足動物防除剤
CN108530606B (zh) * 2018-04-19 2020-11-20 山东师范大学 一种pH敏感性医用聚氨酯脲材料及其制备方法
CN110483740B (zh) * 2019-08-12 2021-08-27 山东师范大学 一种聚合物、pH敏感性纳米囊泡及制备方法与应用

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3409626A (en) * 1963-09-17 1968-11-05 Neisler Lab Inc Indolylethyl pyridinium quaternary ammonium compounds
NL144484B (nl) * 1967-07-26 1975-01-15 Merck & Co Inc Werkwijze ter bereiding van een geneesmiddel met anti-anflammatoire werking, alsmede werkwijze ter bereiding van de anti-inflammatoir werkzame aralkylmercaptoaminozuren.
US3558640A (en) * 1967-12-20 1971-01-26 Merck & Co Inc Certain pyridyl and thiazolyl methylthiopropionic acids and derivatives
US3636074A (en) * 1968-08-05 1972-01-18 Hooker Chemical Corp Novel mercaptophenol derivatives
US3591584A (en) 1968-08-27 1971-07-06 Pfizer Benzothiazine dioxides
US3818009A (en) * 1969-12-29 1974-06-18 Lilly Co Eli Alpha, alpha-disubstituted-5-pyrimidinemethanes
US3676463A (en) 1970-10-15 1972-07-11 Pfizer Oxobenzofuran carboxamides
US3707475A (en) 1970-11-16 1972-12-26 Pfizer Antiinflammatory imidazoles
JPS52125170A (en) * 1976-04-12 1977-10-20 Yoshitomi Pharmaceut Ind Ltd Pyridine derivatives

Also Published As

Publication number Publication date
SG56384G (en) 1985-03-08
CH646425A5 (fr) 1984-11-30
PT71917A (en) 1980-12-01
DE3038593A1 (de) 1981-04-23
CS226034B2 (en) 1984-03-19
LU82844A1 (fr) 1981-06-04
FR2467199B1 (ko) 1984-12-28
IT8025324A0 (it) 1980-10-14
ATA268783A (de) 1985-07-15
ZA806306B (en) 1981-10-28
NO803073L (no) 1981-04-21
FR2467199A1 (fr) 1981-04-17
AT379801B (de) 1986-03-10
SU1083907A3 (ru) 1984-03-30
IT1195269B (it) 1988-10-12
PT71917B (en) 1983-01-10
SU1144617A3 (ru) 1985-03-07
KR830004263A (ko) 1983-07-09
KE3466A (en) 1984-11-09
DK403080A (da) 1981-04-16
US4246263A (en) 1981-01-20
CS226020B2 (en) 1984-03-19
AU6324080A (en) 1981-04-30
JPS6129342B2 (ko) 1986-07-05
CA1156231A (en) 1983-11-01
ES505544A0 (es) 1982-08-16
PH18277A (en) 1985-05-17
YU266882A (en) 1983-09-30
ATA508980A (de) 1984-08-15
AR227576A1 (es) 1982-11-15
IL61261A (en) 1984-08-31
KE3461A (en) 1984-10-12
JPS5663962A (en) 1981-05-30
YU262680A (en) 1983-09-30
IE802125L (en) 1981-04-15
ES495932A0 (es) 1982-01-16
AR227089A1 (es) 1982-09-15
GB2061928B (en) 1983-06-02
IN154554B (ko) 1984-11-10
PL125402B1 (en) 1983-05-31
DD202543A5 (de) 1983-09-21
FI75560C (fi) 1988-07-11
DE3038593C2 (ko) 1988-11-10
DD154816A5 (de) 1982-04-21
IN163553B (ko) 1988-10-08
HU183233B (en) 1984-04-28
GR70311B (ko) 1982-09-08
SE437023B (sv) 1985-02-04
FI803239L (fi) 1981-04-16
GB2092133A (en) 1982-08-11
PL227307A1 (ko) 1981-11-13
HK66887A (en) 1987-09-25
YU41740B (en) 1987-12-31
DK152427B (da) 1988-02-29
MY8500325A (en) 1985-12-31
ES8201972A1 (es) 1982-01-16
SE8007193L (sv) 1981-04-16
IE50665B1 (en) 1986-06-11
PL125314B1 (en) 1983-04-30
SG69184G (en) 1985-03-15
GB2061928A (en) 1981-05-20
NL8005652A (nl) 1981-04-21
AU517763B2 (en) 1981-08-27
AR226864A1 (es) 1982-08-31
FI75560B (fi) 1988-03-31
BE885709A (fr) 1981-04-14
NO156566B (no) 1987-07-06
KR840001615B1 (ko) 1984-10-11
IL61261A0 (en) 1980-12-31
EG14676A (en) 1985-03-31
YU42059B (en) 1988-04-30
NO156566C (no) 1987-10-14
DK152427C (da) 1988-07-25
HK1185A (en) 1985-01-11
MY8500323A (en) 1985-12-31
NZ195246A (en) 1983-07-15
KR840001614B1 (ko) 1984-10-11
AT377513B (de) 1985-03-25
PL231782A1 (ko) 1982-03-01
ES8206478A1 (es) 1982-08-16
GB2092133B (en) 1983-03-16
HU191824B (en) 1987-04-28

Similar Documents

Publication Publication Date Title
DE2922523C2 (de) Aminothiazole und diese enthaltende Arzneimitte l
DE2458965B2 (de) 3-Amino-indazol-N-carbonsäure-Derivate, Verfahren zu ihrer Herstellung sowie sie enthaltende Arzneimittel
DD247451A5 (de) Verfahren zur herstellung von benzothiazindioxid-derivate
DD202568A5 (de) Verfahren zur herstellung wasserloeslicher benzothiazindioxid-salze
DD154816B3 (de) Verfahren zur herstellung neuer pyridine
DE3035086A1 (de) Cyclohexancarbonsaeurederivate, verfahren zu ihrer herstellung und sie enthaltende mittel
DE2263100C2 (de) 5,5-Dimethyl-8-(3-methyl-2-octyl)-10-[4-(piperidino)-butyryloxy]-2-(2-propinyl)-1,2,3,4-tetrahydro-5H-[1]-benzopyrano[3,4-d]pyridin, Verfahren zu dessen Herstellung und die Verbindung enthaltende Arzneimittel
DE2929760C2 (ko)
DE1745780B2 (de) 1-sulfonylaethyl-2-methyl-5-nitroimidazole und verfahren zu ihrer herstellung
DE1670183A1 (de) Tetrazolderivate und Verfahren zu ihrer Herstellung
DE2847624A1 (de) Arylaether von n-alkyl-piperidinen und deren saeureadditionssalze, verfahren zu ihrer herstellung und ihre verwendung
DE3113087C2 (de) 1,4-Disubstituierte Piperazine, deren Salze, Verfahren zu ihrer Herstellung und diese Verbindungen enthaltende Arzneimittel
DE3337925C2 (de) N-(6-Aminopurinyl)-4-hydroxy-2-methyl-2H-1,2-benzothiazin-3-carboxamid-1,1-dioxid, Verfahren zu dessen Herstellung und seine Verwendung
DE2923817C2 (de) (3-Alkylamino-2-hydroxyproposy)-furan-2-carbonsäureanilide und deren physiologisch verträgliche Säureadditionssalze und Verfahren zu deren Herstellung sowie Arzneimittel mit einem Gehalt dieser Verbindungen
DE3215648A1 (de) Arzneimittel mit neuen entzuendungshemmenden und immunregulatorischen pyridinen
DE2640884A1 (de) Neue entzuendungshemmende l-oxo-isoindolin-derivate und verfahren zu ihrer herstellung
DE3020421A1 (de) Imidazoazolalkensaeureamide, neue zwischenprodukte zu ihrer herstellung, ihre herstellung und ihre verwendung in arzneimitteln
DE2412388A1 (de) Dibenzothiophenderivate, verfahren zu deren herstellung und sie enthaltende arzneimittel
DE2656678C2 (de) 4-Amino-trans-decahydrochinolin-Derivate und Verfahren zu deren Herstellung und diese enthaltende pharmazeutische Zusammensetzungen
CH650241A5 (de) Phenylessigsaeurederivate, ihre herstellung und pharmazeutische praeparate.
AT354432B (de) Verfahren zur herstellung von 3-indolylessig- saeuren
DE2222931C3 (de) Piperidinoalkylphenthiazine, Verfahren zur Herstellung derselben sowie diese enthaltende pharmazeutische Mittel
DE3726381A1 (de) Guanidincarbonsaeureester, verfahren zu ihrer herstellung und diese verbindungen enthaltende arzneimittel
EP0011092A1 (de) Alpha-Aminophenylessigsäurederivate zur Verwendung bei der Behandlung von Entzündungen sowie neue alpha-Aminophenylessigsäurederivate
EP0090353A1 (de) Pyridon-2-derivate, Verfahren zu ihrer Herstellung und sie enthaltende Arzneimittel

Legal Events

Date Code Title Description
NPV Change in the person, the name or the address of the representative (addendum to changes before extension act)
ENJ Ceased due to non-payment of renewal fee